Source: Annual Congress 2003 - Staging and outcome in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. E. Delea, R. H. Stanford, M. Hagiwara, J. S. Edelsberg, G. Oster (Brookline, Research Triangle Park, United States Of America). Initial treatment and mortality in COPD. Eur Respir J 2003; 22: Suppl. 45, 3629

Member's Comments

No comment yet.

Related content which might interest you: Predictors of mortality in COPD Source: Annual Congress 2009 - Prognosis and comorbidities in COPD Year: 2009 Predictors of mortality in COPD Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia Source: Eur Respir J 2014; 43: 36-42 Year: 2004 Pharmacological management and risk of mortality after first COPD hospitalization (HERA) Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Predictors of mortality in COPD during acute exacerbation Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Efficiency of therapy of COPD exacerbations and 1-year survival rate after hospitalization Source: Eur Respir J 2007; 30: Suppl. 51, 556s Year: 2007 Evaluation of costs of inhospital treatment of COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 64s Year: 2004 Adherence to treatment strategies correlates with the annual rate of hospitalizations and 1-year mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Predictors of mortality in a well-characterised group of patients with COPD Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012 No impact of statins on time to first COPD exacerbation or all-cause mortality Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Mortality predictors in COPD exacerbation Source: Annual Congress 2010 - COPD exacerbation Year: 2010 COPD mortality after severe exacerbations Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020 In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015 Statins and outcome of COPD patients after hospitalization for COPD exacerbations Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008 Statin use is associated with reduced mortality in COPD Source: Eur Respir J 2007; 29: 279-283 Year: 2007 Risk factors for mortality in patients with COPD exacerbation Source: Annual Congress 2009 - Epidemiology of COPD Year: 2009